Advertisement

Topics

Aduro Biotech’s Chief Medical Officer Sacks to Resign in October

11:06 EDT 19 Sep 2018 | Xconomy

Natalie Sacks will resign from her position as chief medical officer of Aduro Biotech (NASDAQ: ADRO) effective Oct. 1, the cancer immunotherapy developer announced Wednesday. Berkeley, CA-based Aduro gave no reason for the resignation, but said that Sacks will continue to advise the company through a consulting agreement. Sacks joined Aduro in 2016. Last year, […]

Original Article: Aduro Biotech’s Chief Medical Officer Sacks to Resign in October

NEXT ARTICLE

More From BioPortfolio on "Aduro Biotech’s Chief Medical Officer Sacks to Resign in October"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...